BOCIC(SH:601696) Xin Lang Cai Jing·2025-10-23 02:55Group 1 - Yifang Biotechnology experienced a decline of 5.09% on October 23, with a stock price of 26.48 yuan per share, a trading volume of 148 million yuan, a turnover rate of 1.32%, and a total market capitalization of 15.315 billion yuan [1] - The company, established on January 11, 2013, and listed on July 25, 2022, is located in the China (Shanghai) Free Trade Pilot Zone and focuses on the research, production, and sales of innovative drugs, with 100% of its main business revenue coming from technology licensing and cooperation [1] Group 2 - According to data, a fund under Bank of China Securities holds a significant position in Yifang Biotechnology, with the Bank of China Health Industry Mixed Fund (002938) reducing its holdings by 260,000 shares in the second quarter, now holding 450,000 shares, which constitutes 9.35% of the fund's net value, making it the largest holding [2] - The Bank of China Health Industry Mixed Fund (002938) was established on September 7, 2016, with a current size of 158 million yuan, achieving a year-to-date return of 41.74% and a one-year return of 27.97%, ranking 1420 out of 8159 and 2547 out of 8030 in its category, respectively [2]